Global Patent Pool Scores 4 New AIDS Drugs

Gilead Sciences announced today that it will license four AIDS and hepatitis B drugs to an international patent pool, allowing cheap, generic versions to be produced for sale in low-income countries. The AIDS drugs, which include tenofovir and emtricitabine, represent a major upgrade on the treatments currently available in those…

See the article here:
Global Patent Pool Scores 4 New AIDS Drugs

Posted by on July 12, 2011. Filed under News, World News. You can follow any responses to this entry through the RSS 2.0. You can skip to the end and leave a response. Pinging is currently not allowed.